Innovative Product Launch Hycor Biomedical recently introduced NOVEOS, a next-generation fully-automated allergy testing system that significantly reduces sample volume and interference, presenting a compelling upgrade opportunity for clinical labs and hospitals seeking advanced diagnostics.

Growing Market Presence With over 40 years of experience in IgE testing and a global customer base including laboratories and medical practices, Hycor’s expanding product lineup offers multiple touchpoints for partnerships or distributors to tap into the allergy diagnostics market.

Strategic Acquisition Backing As a subsidiary of Agilent Technologies since 2007, Hycor benefits from strong corporate backing and stability, making it an attractive partner for large healthcare providers and OEM collaborations interested in integrated diagnostic solutions.

Revenue and Funding Signals Operating with an estimated revenue between 10 and 25 million dollars and a recent funding of 10 million dollars, Hycor is positioned for growth and product innovation, offering opportunities for investment or joint ventures in expanding allergy diagnostics solutions.

Tech Stack and Digital Presence Hycor’s digital presence via Wix and analytics tools indicates an adaptable online marketing approach, creating opportunities to enhance outreach efforts towards healthcare providers and to engage directly with potential customers or distributors through targeted campaigns.